Label: information for the user
Toctino30mg soft capsules
alitretinoína
WARNING IF PREGNANT, IT MAY SERIOUSLY HARM THE BABY. Women must use effective birth control during the entire treatment. Do not use if pregnant or think you may be pregnant |
Read this label carefully before starting to take this medicine, as it contains important information for you.
The active ingredient of Toctino is alitretinoin. It belongs to a group of medicines known asretinoids, which are derived from vitamin A. Toctino capsules are marketed in two doses containing 10mg or 30mg of alitretinoin.
Toctino is used to treat chronic hand eczema in adult patients, who have not improved after any other topical treatment, including corticosteroids. Treatment with Toctino must be supervised by a specialist skin doctor (dermatologist).
Do not take Toctino
Do not take Toctino.
Warnings and Precautions
Pregnancy Prevention Plan
This medication can severely harm the baby (the medication is considered "teratogenic") - it can cause severe brain, face, ear, eye, heart and certain gland abnormalities in the baby (thyroid and parathyroid). It also increases the risk of spontaneous abortion. This can happen even if Toctino is taken only for a short period of time during pregnancy.
Pregnant women who may become pregnant are prescribed Toctino under strict rules. This is due to the risk of severe harm to the baby.
These are the rules:
Pregnant women must use effective birth control before, during and after taking Toctino
Pregnant women must agree to have pregnancy tests before, during and after taking Toctino
If you become pregnant while taking Toctino,stop taking the medication immediatelyand consult your doctor. Your doctor may send you to a specialist to advise you.
Also, if you become pregnant within a month of stopping Toctino, you must consult your doctor. Your doctor may send you to a specialist to advise you.
Advice for men
The levels of oral retinoids in the semen of men taking Toctino are too low to harm their partners' babies. However, you should never share your medication with anyone.
Additional precautions
You must never give this medication to anyone else. Please take any unused capsules to your pharmacist at the end of treatment.
You must not donate blood during treatment with this medication, nor during 1 month after stopping Toctino because a baby could be harmed if a pregnant woman receives your blood.
Consult your doctor before starting to take Toctino:
Be extra careful during treatment with Toctino:
Stop taking the capsulesimmediately and contact your doctor as soon as possible.
Mental health problems
Children and adolescents
Toctino is not recommended for use in children under 18 years of age. Its effectiveness in this age group is unknown.
Combination of Toctino with other medications
Do not take other medications that contain retinoids (for example isotretinoína), vitamin A supplements or tetracyclines(a type of antibiotic) while taking Toctino,as they increase the risk of adverse effects.
Inform your doctor or pharmacist:
Inform your doctor or pharmacistif you are using, have used recently or may need to use any other medication,including those obtained without a prescription. This includes also herbal medications.
Do not take Toctinoduring breastfeeding.
Do not take Toctino if you are pregnant
Toctino is likely to cause congenital malformations (in medical language, it is teratogenic). It also increases the risk of spontaneous abortion.
For more information on pregnancy and birth control, see the "Pregnancy Prevention Plan", in section 2.
Driving and operating machines
Your vision may not be as good at nightduring treatment. If this happens, you must not drive or operate machines.
Toctino contains soy oil and sorbitol
It should not be used in case of allergy to peanuts or soy. If your doctor has told you that you have an intolerance to certain sugars, consult with him before taking Toctino.This medication contains 25.66 mg of sorbitol in each capsule.
When to Take the Capsules
The capsule should be taken with a main meal, preferably at the same time every day. The capsules should be swallowed whole and not chewed.
How Much to Take
The dose is 10 mg or 30 mg per day. If your body cannot tolerate the recommended dose of 30 mg, you may be prescribed the lower dose of 10 mg.
Follow exactly the administration instructions for this medication as indicated by your doctor. In case of doubt, consult again with your doctor or pharmacist.
How Long to Take the Capsules
Treatment cycles usually last between 12 and 24 weeks, depending on how the disease improves. If your first treatment was successful, your doctor may prescribe another treatment cycle if symptoms reappear.
If You Take More Toctino Than You Should
If you take too many capsules or if another person accidentally takes your medication, contact your doctor, pharmacist, or go to the nearest hospital immediately.
In case of overdose or accidental ingestion, consult the Toxicological Information Service, phone: 91 562 04 20. It is recommended to bring the packaging and the leaflet of this medication to the healthcare professional.
If You Forget to Take Toctino
If you forget to take a dose, take it as soon as you can.However, if it is almost time to take the next dose, skip the missed dose and continue as usual.
Do not take a double dose to compensate for the missed doses.
Very common: | can affect more than 1 in 10 people |
Common: | can affect up to 1 in 10 people |
Uncommon: | can affect up to 1 in 100 people |
Rare: | can affect up to 1 in 1,000 people |
Very common side effects
Common side effects
Uncommon side effects
Rare side effects
Mental health problems
Rare side effects(can affect up to 1 in 1,000 people)
Very rare side effects(can affect up to 1 in 10,000 people)
Contact your doctor immediately if you experience any signs of these mental health problems.Your doctor may tell you to stop taking Toctino. This may not be enough to stop the effects: you may need more help and your doctor may manage it.
Other side effects
In a very small number of people, other side effects have occurred whose exact frequency is unknown:
Severe allergic reactions.The signs include:
Intestine and stomach disorders.Severe stomach pain (abdominal), with or without bloody diarrhea, nausea, and vomiting.
Night vision problems.The vision problems usually return to normal once treatment is stopped.
Blood and circulation disorders.Swelling in the hands, lower legs, and feet (peripheral edema).
Side effects of other medicines in the same class as Toctino
These side effects have not been observed with Toctino to date, but cannot be ruled out.They are very rare and may affect fewer than 1 in 10,000 people.
Diabetes.Excessive thirst, frequent need to urinate, blood tests showing an increase in blood sugar levels.All of these may be signs of diabetes.
Bone disorders.Arthritis, bone disorders (delayed growth, changes in bone density). Growing bones may stop growing.
Eye and vision disorders.Worsening ofcolor blindness and color vision, intolerance to contact lenses.
Reporting side effects
If you experience any type of side effect, consult your doctor or pharmacist, even if it is a possible side effect that does not appear in this leaflet. You can also report them directly through theSpanish System for the Pharmacovigilance of Medicines for Human Use: www.notificaRAM.es. By reporting side effects, you can contribute to providing more information on the safety of this medicine.
Keep this medication out of the sight and reach of children.
Do not use this medication after the expiration date that appears on the packaging and blister pack after CAD.The expiration date is the last day of the month indicated.
Do not store at a temperature above30°C.Store the blister pack in the outer packaging to protect it from light.
Medications should not be disposed of through drains or in the trash.Deposit the packaging and medications you no longer need at the SIGRE collection point at the pharmacy. If in doubt, ask your pharmacist how to dispose of the packaging and medications you no longer need. In this way, you will help protect the environment.
Appearance of the product and contents of the package
Toctino 30mg soft capsules arereddish-brown, oval, approximately 13 mm in length and8 mmin width, printed with “A3”. The capsules are packaged in blisters and presented in boxes of 30 capsules.
Marketing Authorization Holder
GlaxoSmithKline, S.A.
P.T.M. C/ Severo Ochoa, 2
28760 Tres Cantos (Madrid)
Tel: + 34 900 202 700
Responsible for manufacturing
SwissCaps GmbH
Grassingerstrasse9
D-83043 Bad Aibling
Germany
This medicine is authorized in the Member States of the European Economic Areaand in the United Kingdom (Northern Ireland)with the following names:
GermanyToctino
AustriaToctino
DenmarkToctino
SlovakiaToctino
SloveniaToctino
SpainToctino
FinlandToctino
FranceToctino
GreeceCehado
NetherlandsToctino
IcelandToctino
ItalyToctino
NorwayToctino
PolandToctino
United Kingdom (Northern Ireland):Toctino
Date of the last review of this leaflet:January 2024.
Detailed and updated information about this product is available by scanning the QR code included in the leaflet through a smartphone. The same information is also available at the following link:http://www.aemps.gob.es
Маєте питання щодо цього лікування або ваших симптомів? Зв'яжіться з ліцензованим лікарем для отримання допомоги та персонального догляду.